No difference in women’s age, BMI, duration of infertility, basal FSH and LH and E2 level, AMH level, antral follicle count (2–10 mm, AFC), serum CA125 level before downregulation, type of infertility, previous ovarian surgery, and type of adenomyosis were found between the two compared strategies. This evidence concerns the gene BRD2 and adenomyosis.